ALELOPHARMA INC.

Medtech · Private

AleloMAX, a high-dimensional molecular detection system for ultra-sensitive, ultra-specific detection of ALK gene fusion translocations in cell-free RNA from blood plasma as a liquid biopsy companion

Grants
$399K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Ultra-precision diagnostics for ALK+ non-small cell lung cancer$399,153
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1713MaGPaD, LLC——
1714STERILE GEEKS VR INC——
1715TIOGA RESEARCH, INC.——
1716ALELOPHARMA INC.——
1717Procyrion, Inc.—$109M
1718EZ LAB LIMITED LIABILITY COMPANY——
1719FHC, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.